Averitas A Grunenthal Company

Formed in 2018, Averitas is the US commercial subsidiary of Grünenthal, a multinational pharmaceutical company with presence across Europe, Latin America, and the US. Grünenthal has been a global leader in research and development of therapeutics for pain, gout, and inflammation. Now, Averitas becomes a new chapter in Grünenthal’s growth.